Search results

• Finished

  The role of Nitric Oxide in cognition in schizophrenia; The NOC Study (Nitric Oxide in Cognition)

  Morrison, P., Taylor, M. & academic, A.

  1/12/2015 → 1/12/2018

  Project: Research

• The role of nitric oxide in cognition in schizophrenia: the NOC Study

  Morrison, P., Taylor, M. & academic, A.

  Guy's & St Thomas' Charity

  1/12/2015 → 31/12/2017

  Project: Research

• The role of Nitric Oxide in cognition in schizophrenia; The NOC Study (Nitric Oxide in Cognition)

  Taylor, M., Morrison, P. & academic, A.

  1/11/2015 → 1/11/2017

  Project: Research

• Intranasal oxytocin for prodromal psychosis

  Fusar-Poli, P., DO NOT USE, P., McGuire, P., Morrison, P., Shergill, S. & Williams, S.

  1/05/2015 → 30/04/2019

  Project: Research

• Sativex for cannabis dependent psychotic patients

  Morrison, P., Di Forti, M., Englund, A. & Murray, R.

  1/04/2015 → 30/09/2016

  Project: Research

• Reversal of neuroimaging effects of ketamine by a transdermal nitric oxide donor: A proof of concept study

  Egerton, A., McGuire, P., Morrison, P. & Stone, J.

  1/04/2015 → 30/09/2016

  Project: Research

• Are the antidepressant effects of ketamine prolonged by lithium treatment?

  Morrison, P., Stone, J. & Young, A.

  1/10/2014 → 30/09/2015

  Project: Research

• MICA - Neurophysiological basis of effects of oxytocin on emotional and social dysfunction and symptoms in people at ultra high risk of psychosis

  Fusar-Poli, P., DO NOT USE, P., McGuire, P., Morrison, P., Shergill, S. & Williams, S.

  1/04/2014 → 1/04/2018

  Project: Research

• Randomized, Double-Blind, Placebo-Controlled, Three-period, Cross-Over Study to Evaluate the Effects of Single Oral Administrations of Roflumilast on Preventing Ketamin-Induced Cognitive Deficits

  Morrison, P.

  Takeda Global R&D Centre (Europe) Ltd

  1/10/2013 → 28/11/2013

  Project: Research

• Evaluation of cannabidiol as a treatment for the early phase of psychosis

  McGuire, P., DO NOT USE, P., Barker, G., Bhattacharyya, S., Bossong, M. & Morrison, P.

  Wellcome Trust

  1/04/2013 → 30/09/2014

  Project: Research

• Cannabidiol as a novel therapeutic agent for patients at ultra-high risk of psychosis: an experimental medicine approach.

  Bhattacharyya, S., Brammer, M., McGuire, P., Morrison, P., Murray, R., Valmaggia, L. & Williams, S.

  MRC Medical Research Council

  2/01/2013 → 1/10/2015

  Project: Research

• Cannabidiol as a novel early therapy in psychotic disorders study 1 non-CTIMP (n=20), Study 2 trial (n=40)

  Kapur, S., McGuire, P., Morrison, P., Murray, R., Pickles, A. & Valmaggia, L.

  1/04/2012 → 1/04/2015

  Project: Research

• The Effect of CBD on paranoid cognitions in humans

  Morrison, P.

  BMA British Medical Association

  1/09/2011 → 31/08/2014

  Project: Research

• The Effect of CBD on paranoid cognitions in humans

  Morrison, P.

  Beckley Foundation

  1/06/2011 → 1/06/2012

  Project: Research

• A Pharmacological Validation of The Joystick Operated Runway Task as A Repeatable and Objective Behavioural Assay of Anxiety in Humans

  Morrison, P.

  Beckley Foundation

  1/02/2011 → 30/10/2011

  Project: Research

• Cannabinoids and Psychosis: Mechanisms and therapeutics

  Morrison, P.

  MRC Medical Research Council

  1/10/2008 → 30/09/2011

  Project: Research

• Cannabinoids in Psychosis: Developing an experimental model and new therapeutics.

  Morrison, P.

  1/04/2008 → 1/10/2009

  Project: Research

• BRC- Does Cannabidiol prevent THC induced psychosis and working memory impairment? (Pump priming from PAXKAZA)

  Morrison, P.

  DHSC Department of Health and Social Care

  1/01/2008 → 1/01/2009

  Project: Research

• Investigating consciousness with Tetrahydrocannabinol

  Morrison, P. & Stone, J.

  Beckley Foundation

  1/08/2007 → 31/07/2009

  Project: Research

• Does cannabis induce psychotic symptoms via dopamine

  McGuire, P., Morrison, P., Pell, V. & Pilowsky, L.

  1/11/2006 → 1/11/2009

  Project: Research